Titan Pharmaceuticals (NASDAQ:TTNP) announced the appointment of Federico Seghi Recli to its board. An executive with over 24 years of leadership experience within the pharmaceutical industry, Mr. Seghi Recli has served...

Profound Medical (TSXV:PRN; OTCQX:PRFMF) strengthened its management team, naming Aaron Davidson as CFO and SVP of corporate development, effective May 3, 2018. In a statement, Arun Menawat, CEO, said Mr. Davidson’s...

Maxim Group expanded its equity research platform with the appointment of Caroline Palomeque as a SVP and a senior biotechnology analyst.

Closely-held CellAegis Devices has appointed Brian Fielding as CFO and Hans Custers as VP of sales and marketing for Europe. The appointments are intended to support global commercialization of the company’s autoRIC...

Ben Haynor has joined Alliance Global Partners as a managing director, focusing on medical technologies, including diagnostics, devices, and select specialty pharmaceutical firms. 

Jason Kolbert, a former a senior managing director with the Maxim Group, and the head of healthcare research as well as a covering analyst, has joined H.C. Wainwright as a managing director of research.

Focused Ultrasound Foundation’s newsletter has published an interview with Arun Menawat, CEO of Profound Medical (OTCQX:PRFMF; TSXV:PRN), in which he discusses the company’s transformation during the past two years and...

Closely-held Soricimed Biopharma has appointed accomplished biotech and pharma Industry veterans, Marc Robin, MD and Vaughn Embry-Pantalony to its board, effective immediately. In a statement, Tom Reeves, chairman, said...

Miranda Toledano has joined H.C. Wainwright's healthcare investment banking team where she will focus on building out the firm's footprint across Europe and Israel.

Eiger BioPharmaceuticals (NASDAQ:EIGR) appointed Eldon Mayer as a director, while Chuck Bramlage has left the board to focus on a newly accepted position as CEO at another start-up company.

Ortho Regenerative Technologies (CSE:ORTH) appointed Sharon Ludlow to the board, succeeding Laurence Rulleau, who has resigned. 

Eiger BioPharmaceuticals (NASDAQ:EIGR) appointed Dr. David Apelian as chief operating officer and executive medical officer.

Ortho Regenerative Technologies (CSE:ORTH) appointed Dr. Jacques Toueg to its scientific advisory board (SAB).

Closely-held Rubius Therapeutics appointed Andrew Oh, who has more than 20 years of experience in finance and the biopharmaceutical industry, as CFO.

Vital Therapies (NASDAQ:VTL) has appointed Russell Cox as CEO and a member of the board, effective January 3, 2018.

Nuvo Pharmaceuticals (TSX:NRI) appointed Jesse Ledger as CEO, succeeding John London who continues as executive chairman and a director.

Novelion Therapeutics (NASDAQ:NVLN) CEO, Mary Szela, has resigned for personal reasons, effective immediately, and the company has begun a search for a new CEO.

Synergy CHC (OTCQB:SNYR) appointed Jeffrey Kadanoff as its CFO, effective Nov, 1, 2017.

Ortho Regenerative Technologies appointed global sports and entertainment veteran, Tom Wright, to the board.

Dr. Jotin Marango and Yasmeen Rahimi have joined the healthcare research team at Roth Capital Partners.